SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001185185-23-001111
Filing Date
2023-10-27
Accepted
2023-10-27 17:21:48
Documents
18
Period of Report
2023-10-27
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K igcpharma20231027_8k.htm   iXBRL 8-K 34980
2 EXHIBIT 5.1 ex_587006.htm EX-5.1 7229
3 EXHIBIT 10.1 ex_587005.htm EX-10.1 246239
8 igcpharma20231027_8kimg001.jpg GRAPHIC 3124
9 img1.jpg GRAPHIC 6391
10 img2.jpg GRAPHIC 4621
  Complete submission text file 0001185185-23-001111.txt   515361

Data Files

Seq Description Document Type Size
4 XBRL TAXONOMY EXTENSION SCHEMA igc-20231027.xsd EX-101.SCH 3206
5 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE igc-20231027_def.xml EX-101.DEF 11028
6 XBRL TAXONOMY EXTENSION LABEL LINKBASE igc-20231027_lab.xml EX-101.LAB 21062
7 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE igc-20231027_pre.xml EX-101.PRE 11429
12 EXTRACTED XBRL INSTANCE DOCUMENT igcpharma20231027_8k_htm.xml XML 2597
Mailing Address 10224 FALLS ROAD POTOMAC MD 20854
Business Address 10224 FALLS ROAD POTOMAC MD 20854 301-983-0998
IGC Pharma, Inc. (Filer) CIK: 0001326205 (see all company filings)

IRS No.: 202760393 | State of Incorp.: MD | Fiscal Year End: 0331
Type: 8-K | Act: 34 | File No.: 001-32830 | Film No.: 231356434
SIC: 2834 Pharmaceutical Preparations